These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials. Nieto JA; Espada NG; Merino RG; González TC Thromb Res; 2012 Aug; 130(2):183-91. PubMed ID: 22425218 [TBL] [Abstract][Full Text] [Related]
27. New antithrombotic drugs and European approval processes. Marijon E; Fauchier L; Le Heuzey JY Lancet; 2011 Aug; 378(9792):662-3. PubMed ID: 21856473 [No Abstract] [Full Text] [Related]
28. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. Lip GY; Larsen TB; Skjøth F; Rasmussen LH J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324 [TBL] [Abstract][Full Text] [Related]
29. [New anticoagulants--should we have a little bit of cold water in the blood?]. Dyrkorn R; Roland PD Tidsskr Nor Laegeforen; 2013 Feb; 133(4):390-1. PubMed ID: 23423204 [No Abstract] [Full Text] [Related]
30. How I treat target-specific oral anticoagulant-associated bleeding. Siegal DM; Garcia DA; Crowther MA Blood; 2014 Feb; 123(8):1152-8. PubMed ID: 24385535 [TBL] [Abstract][Full Text] [Related]
31. [Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests]. Nagler M; Wuillemin W Ther Umsch; 2012 Nov; 69(11):650-6. PubMed ID: 23117668 [TBL] [Abstract][Full Text] [Related]
32. Managing new oral anticoagulants in the perioperative and intensive care unit setting. Levy JH; Faraoni D; Spring JL; Douketis JD; Samama CM Anesthesiology; 2013 Jun; 118(6):1466-74. PubMed ID: 23416382 [TBL] [Abstract][Full Text] [Related]
33. Strategies for urgent reversal of target-specific oral anticoagulants. Davis EM; Uhlmeyer EM; Schmidt DP; Schardt GL Hosp Pract (1995); 2014 Dec; 42(5):108-25. PubMed ID: 25485923 [TBL] [Abstract][Full Text] [Related]
34. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation. Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607 [TBL] [Abstract][Full Text] [Related]
35. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation. Berman JP; Halperin JL Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966 [TBL] [Abstract][Full Text] [Related]
36. New oral anticoagulants: an emergency department overview. Wood P Emerg Med Australas; 2013 Dec; 25(6):503-14. PubMed ID: 24224462 [TBL] [Abstract][Full Text] [Related]
37. New oral anticoagulants after acute coronary syndrome. Bennaghmouch N; Ten Berg JM Best Pract Res Clin Haematol; 2013 Jun; 26(2):141-50. PubMed ID: 23953902 [TBL] [Abstract][Full Text] [Related]
38. The laboratory and the new oral anticoagulants. Tripodi A Clin Chem; 2013 Feb; 59(2):353-62. PubMed ID: 23043068 [TBL] [Abstract][Full Text] [Related]
39. [Atrial fibrillation: what the GP needs to know]. Diener HC; Kaeufer T; Bode C MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796 [No Abstract] [Full Text] [Related]